10-Q: Evolv Technologies Restates Financials Amid Sales Practice Investigation, Reports Q3 2024 Results

Evolv Technologies restates prior financial statements due to revenue recognition errors stemming from sales practice irregularities, while also reporting a net loss for Q3 2024.

Summary

• Evolv Technologies Holdings, Inc. has restated its previously issued consolidated financial statements for fiscal years 2022 and 2023, as well as interim periods in 2022, 2023 and 2024, due to misstatements related to accounting for certain sales transactions.
• An internal investigation revealed that certain sales were subject to extra-contractual terms and conditions that impacted revenue recognition.
• The company's Chief Financial Officer resigned in November 2024, and four other employees were terminated or resigned as a result of the investigation.
• For the three months ended September 30, 2024, Evolv reported a net loss of $30.4 million, compared to a net income of $5.0 million for the same period in 2023.
• Total revenue for the quarter was $27.4 million, up from $20.0 million in 2023.
• For the nine months ended September 30, 2024, the company reported a net loss of $38.3 million, compared to a net loss of $90.9 million for the same period in 2023.
• Total revenue for the nine-month period was $74.8 million, up from $59.0 million in 2023.
• The company expects its cash, cash equivalents, and marketable securities of $56.0 million as of September 30, 2024, together with cash it expects to generate from future operations, will be sufficient to fund its operating expenses and capital expenditure requirements for a period of at least twelve months from the date of this Quarterly Report on Form 10-Q.
• The company identified material weaknesses in its internal control over financial reporting, which contributed to the restatement.
• Management is taking steps to remediate these material weaknesses.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While revenue increased, the restatement of financials and identification of material weaknesses in internal control are significant concerns. The company's ability to fund operations for the next twelve months provides some stability, but the overall outlook is cautiously negative.

Positives

• Revenue increased for both the three and nine months ended September 30, 2024, compared to the same periods in 2023.
• Net loss decreased for the nine months ended September 30, 2024, compared to the same period in 2023.
• The company believes its current cash reserves are sufficient to fund operations for at least the next twelve months.
• Management is actively taking steps to remediate the identified material weaknesses in internal control over financial reporting.

Negatives

• The company restated its financial statements for multiple periods due to revenue recognition misstatements.
• An internal investigation revealed extra-contractual terms and conditions affecting sales transactions.
• The company reported a net loss for the three months ended September 30, 2024, compared to a net income for the same period in 2023.
• Material weaknesses in internal control over financial reporting were identified.

Risks

• The company's ability to forecast future operating results is subject to a number of uncertainties.
• The company may require additional capital to support business growth, which might not be available on acceptable terms, if at all.
• The market price of the company's common stock and warrants has been and may continue to be highly volatile.
• The company is subject to government regulation and other legal obligations, particularly related to privacy, data protection, information security, and product marketing and its actual or perceived failure to comply with such obligations could harm its business.
• The company is and may in the future be subject to legal proceedings, claims and investigations.
• The company is and may in the future be subject to litigation and regulatory examinations, investigations, proceedings or orders as a result of or relating to the Investigation and its failure to timely file its periodic reports with the SEC.

Future Outlook

The company expects its cash, cash equivalents, and marketable securities of $56.0 million as of September 30, 2024, together with cash it expects to generate from future operations, will be sufficient to fund its operating expenses and capital expenditure requirements for a period of at least twelve months from the date of this Quarterly Report on Form 10-Q.

Management Comments

• Our new leadership team, together with other senior executives, is committed to achieving and maintaining a strong control environment, high ethical standards, and financial reporting integrity.
• This commitment will be communicated to and reinforced with every Evolv employee and external stakeholders.

Industry Context

The document highlights the increasing focus on safety and security in public gathering places and the shift towards frictionless security screening experiences, positioning Evolv as a key player in this evolving market.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or competitors.
• It focuses on the company's internal performance and remediation efforts rather than benchmarking against external entities.
• Without specific competitor data or industry benchmarks, it's difficult to assess Evolv's performance relative to its peers.

Management Changes

Corporate Governance

Legal Proceedings

• A putative class action lawsuit was filed against the company in the United States District Court for the District of Massachusetts.
• A shareholder derivative lawsuit was filed in the United States District Court for the District of Massachusetts.
• A shareholder derivative lawsuit was filed in the Delaware Court of Chancery.
• The Company reached a settlement with the FTC and on December 5, 2024, a Stipulated Order for Permanent Injunction and Other Relief (the Order) was entered in the United States District Court for the District of Massachusetts Eastern Division.
• The Company has since received requests for documents and information from the SEC relating to this matter.
• The Company received a voluntary document request from the U.S. Attorneys Office of the Southern District of New York relating to these same issues and has since received additional requests for documents and information relating to this matter.

Related Party Transactions

• Revenue from Motorola's distributor services was $2.2 million and $1.7 million during the three months ended September 30, 2024 and 2023, respectively.
• Revenue from Motorola's distributor services was $6.1 million and $7.9 million, respectively, which was a result of the Company's transition to pure subscription sales and sales under the distributor licensing model during this period.
• As of September 30, 2024 and December 31, 2023, accounts receivable related to Motorolas distributor services was $1.1 million and $1.6 million, respectively.

Stakeholder Impact

• Shareholders: Face potential dilution from future equity issuances and volatility in stock price.
• Employees: Experienced a reduction in force in January 2025.
• Customers: May experience improved product reliability and support as a result of remediation efforts.
• Suppliers: May be affected by changes in manufacturing and sourcing strategies.

Next Steps

• The company is taking steps to remediate the material weaknesses in its internal control over financial reporting.
• The company will continue to assess the need for new systems for which IT general controls will be designed and implemented.

Key Dates

Keywords

restatement, revenue recognition, internal control, financial statements, material weakness, sales practices, Evolv Technologies, investigation, SEC, financial results